Nervgen Pharma Corp. (NGEN) closed at $1.88 on November 13, 2026, up 15.3% from the previous close, on volume of 1,882,034 shares (30-day average 485,002).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury
Globe Newswire (Thu, 12-Nov 7:15 AM ET)
Globe Newswire (Mon, 12-Oct 7:15 AM ET)
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
Globe Newswire (Fri, 25-Sep 4:30 PM ET)
NervGen to Host Inaugural R&D Day on September 30, 2026
Globe Newswire (Wed, 9-Sep 7:30 AM ET)
Market Chameleon (Tue, 26-May 6:33 AM ET)
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
Nervgen Pharma Corp. trades on the NASDAQ stock market under the symbol NGEN.
As of November 13, 2026, NGEN stock price climbed to $1.88 with 1,882,034 million shares trading.
NGEN has a beta of 2.00, meaning it tends to be more sensitive to market movements. NGEN has a correlation of 0.07 to the broad based SPY ETF.
NGEN has a market cap of $202.14 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that NGEN belongs to (by Net Assets): GWX, IBRN.
NGEN support price is $1.55 and resistance is $1.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NGEN shares will trade within this expected range on the day.
